Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fosfomycin Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115417895A reveals a safer microchannel hydrogenation process for cis-propenyl phosphoric acid, offering >97% selectivity and reduced catalyst costs for fosfomycin production.
Patent CN116947923A reveals low-cost catalyst methods for fosfomycin intermediates. Enhance supply chain reliability and reduce manufacturing costs significantly.
Novel patent CN115677771A offers efficient fosfomycin intermediate production with reduced costs and high purity for reliable pharmaceutical supply chains.